Device Foot and Ankle Implants

Silverback

Payments companies reported to CMS as associated with Silverback. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$11Kassociated payments (2023-2025)

150clinicians with associated payments

1company reporting

By year

2023 $6,833

2024 $1,490

2025 $2,551

Payments reported as associated with Silverback, per program year, as reported to CMS.

Who makes it

Paragon 28, INC. $11K associated with Silverback (2023-2025)

Specialties most often involved

Foot & Ankle Surgery $5,287

Orthopaedic Surgery $2,003

Podiatrist $1,506

Foot and Ankle Surgery $1,019

Hand Surgery $165

Sports Medicine (Orthopaedic Surgery) $95.29

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Silverback

These are the largest totals companies reported as associated with Silverback. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Mark Prissel	Worthington, OH	Foot & Ankle Surgery	$775.11
Charles Saltzman	Salt Lake City, UT	Orthopaedic Surgery	$277.01
David Waters	Hastings, NE	Foot & Ankle Surgery	$274.70
Bryce Bucklew	Kansas City, MO		$205.28
Simon Burke	Kansas City, MO		$190.33
Kevin Schafer	New York, NY	Foot and Ankle Surgery	$164.88
Anna Green	Warrenton, VA	Hand Surgery	$164.88
Justin Fleming	Somerset, NJ	Podiatrist	$164.88
Joanne Balkaran	Tavares, FL	Foot & Ankle Surgery	$149.56
Paul Thurston	Orange City, FL	Foot & Ankle Surgery	$149.56

Prescribed Silverback?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.